InsidersTradesSigma
Follow the Jiangsu Recbio Technology Co., Ltd. - B stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Operating in the Technology sector, Jiangsu Recbio Technology Co., Ltd. - B has recorded 5 insider filings. Market capitalisation: €3.2bn. The latest transaction was disclosed on 6 May 2026 (Sale). Among the most active insiders: LIU YONG. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
3 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,848 of 29,063 companies
29.2
score / 100
Value11
Quality48
FCF yld-19%
Earn yld-19%
EV/EBITDA·
ROE-143%
Gross mgn88%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 May 2026
Declarations5 total
5 of 5 declarations
关于 Jiangsu Recbio Technology Co., Ltd. - B
江苏瑞博生物技术股份有限公司是一家专注于生物制药技术开发的公司。该公司在香港证券交易所上市，股票代码为XHKG。